Purchases and Sales Made in Q3 2021 in Ngm Biopharmaceuticals Inc (NGM)
This table provides information about the institutional ownership of Ngm Biopharmaceuticals Inc (NGM) during Q3 2021. The information is specifically focused on institutions that hold shares of NGM BIOPHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2021
Q3 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-49.1K- 11.33% |
$990K - $1.29M
|
385K
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-97.3KClosed |
$1.96M - $2.55M
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-287K- 10.29% |
$5.79M - $7.53M
|
2.51M
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Euclidean Capital LLC
New York, NY |
SELL
|
- |
-661K- 44.27% |
$13.3M - $17.3M
|
832K
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Aquilo Capital Management, LLC
San Francisco, CA |
SELL
|
- |
-1.19MClosed |
$24.1M - $31.3M
|
0
$0
|